Appeal No. 2002-1479 Page 8 Application No. 08/794,042 Although the examiner correctly notes that the enzyme preparation of both the prior art and the specification ultimately are derived from a bovine source, that fact alone does not necessarily mean that both preparations contain the identical enzyme. In particular, the record contains no evidence regarding how the commercial preparation of enterokinase was purified, thus indicating a potential explanation for the apparent differences between the prior art and claimed enzymes. Thus, the evidence of record shows that the claimed enzyme differs from the prior art enzyme in a number of properties, including molecular weight, number of amino acids, and amino acid composition. In view of these differences, we conclude that the evidence is insufficient to support a prima facie case of anticipation by inherency and we therefore reverse the rejection under 35 U.S.C. § 102(b). REVERSED Sherman D. Winters ) Administrative Patent Judge ) ) ) ) BOARD OF PATENT Demetra J. Mills ) Administrative Patent Judge ) APPEALS AND ) ) INTERFERENCES ) Eric Grimes ) Administrative Patent Judge ) EG/dymPage: Previous 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007